These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32057169)

  • 1. The potential role of chitosan-based nanoparticles as drug delivery systems in pancreatic cancer.
    Sadoughi F; Mansournia MA; Mirhashemi SM
    IUBMB Life; 2020 May; 72(5):872-883. PubMed ID: 32057169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan and Wnt/β-catenin Signaling Pathways in Different Cancers.
    Eslahi M; Sadoughi F; Asemi Z; Yousefi B; Mansournia MA; Hallajzadeh J
    Comb Chem High Throughput Screen; 2021; 24(9):1323-1331. PubMed ID: 33081676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan-Based Drug Delivery Systems for Optimization of Photodynamic Therapy: a Review.
    Calixto GMF; de Annunzio SR; Victorelli FD; Frade ML; Ferreira PS; Chorilli M; Fontana CR
    AAPS PharmSciTech; 2019 Jul; 20(7):253. PubMed ID: 31309346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechology-based strategies to enhance the efficacy of photodynamic therapy for cancers.
    Li WT
    Curr Drug Metab; 2009 Oct; 10(8):851-60. PubMed ID: 20214580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan-based nanotherapeutics for ovarian cancer treatment.
    Alizadeh L; Zarebkohan A; Salehi R; Ajjoolabady A; Rahmati-Yamchi M
    J Drug Target; 2019 Sep; 27(8):839-852. PubMed ID: 30596291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances in Nanoparticle-Mediated Diagnosis and the Treatment of Pancreatic Cancer.
    Nedelcu A; Mocan T; Grapa C; Mocan L
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor targeting strategies for chitosan-based nanoparticles.
    Zhang X; Yang X; Ji J; Liu A; Zhai G
    Colloids Surf B Biointerfaces; 2016 Dec; 148():460-473. PubMed ID: 27665379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment.
    Choukaife H; Seyam S; Alallam B; Doolaanea AA; Alfatama M
    Int J Nanomedicine; 2022; 17():3933-3966. PubMed ID: 36105620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Nanobiotechnology in Drug Delivery.
    Jain KK
    Methods Mol Biol; 2020; 2059():55-73. PubMed ID: 31435915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorinated Chitosan To Enhance Transmucosal Delivery of Sonosensitizer-Conjugated Catalase for Sonodynamic Bladder Cancer Treatment Post-intravesical Instillation.
    Li G; Wang S; Deng D; Xiao Z; Dong Z; Wang Z; Lei Q; Gao S; Huang G; Zhang E; Zeng G; Wen Z; Wu S; Liu Z
    ACS Nano; 2020 Feb; 14(2):1586-1599. PubMed ID: 32011860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Advances in Chitosan-based Drug Delivery Systems for Colorectal Cancer: A Narrative Review.
    Ali DS; Othman HO; Anwer ET
    Curr Pharm Biotechnol; 2023; 24(12):1554-1559. PubMed ID: 36733239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan nanopolymers: An overview of drug delivery against cancer.
    Shanmuganathan R; Edison TNJI; LewisOscar F; Kumar P; Shanmugam S; Pugazhendhi A
    Int J Biol Macromol; 2019 Jun; 130():727-736. PubMed ID: 30771392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan nanoparticles: a promising system in novel drug delivery.
    Nagpal K; Singh SK; Mishra DN
    Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1423-30. PubMed ID: 21048331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotechnology in bladder cancer: current state of development and clinical practice.
    Tomlinson B; Lin TY; Dall'Era M; Pan CX
    Nanomedicine (Lond); 2015; 10(7):1189-201. PubMed ID: 25929573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The new era of pancreatic cancer treatment: Application of nanotechnology breaking through bottlenecks.
    Luo W; Zhang T
    Cancer Lett; 2024 Jul; 594():216979. PubMed ID: 38795762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular uptake pathway and drug release characteristics of drug-encapsulated glycol chitosan nanoparticles in live cells.
    Park S; Lee SJ; Chung H; Her S; Choi Y; Kim K; Choi K; Kwon IC
    Microsc Res Tech; 2010 Sep; 73(9):857-65. PubMed ID: 20232459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano-Chitosan Particles in Anticancer Drug Delivery: An Up-to-Date Review.
    Kamath PR; Sunil D
    Mini Rev Med Chem; 2017; 17(15):1457-1487. PubMed ID: 28245780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
    Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
    ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucin-based targeted pancreatic cancer therapy.
    Torres MP; Chakraborty S; Souchek J; Batra SK
    Curr Pharm Des; 2012; 18(17):2472-81. PubMed ID: 22372499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of molecular weight on the oleoyl-chitosan nanoparticles as carriers for doxorubicin.
    Zhang J; Chen XG; Sun GZ; Huang L; Cheng XJ
    Colloids Surf B Biointerfaces; 2010 Jun; 77(2):125-30. PubMed ID: 20172698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.